<DOC>
	<DOCNO>NCT02291016</DOCNO>
	<brief_summary>The purpose study compare drug delivery lung function treatment formoterol nebulizer versus dry powder inhaler ( DPI ) patient recover severe exacerbation COPD . This determine one device superior provide well lung function drug deposition clinical setting .</brief_summary>
	<brief_title>COPD Aerosol Study Comparing Efficacy Nebulizers Versus Dry Powder Inhalers</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Formoterol Fumarate</mesh_term>
	<criteria>Current past cigarette smoke history &gt; /= 10 packyears . FEV1/FVC ratio &lt; /= 70 % . Known diagnosis COPD . Current hospitalization primary diagnosis acute exacerbation COPD . Must able understand willing sign inform consent document . On ventilator mask ventilation . Allergy contraindication Formoterol use . Marked QTc prolongation ( &gt; 450 m ) . Liver cirrhosis chronic renal insufficiency ( serum creatinine &gt; 2 mg/dL ) . Atrial fibrillation rapid ventricular response ( heart rate &gt; 110 bpm ) ventricular arrhythmia ( frequent PVCs , ventricular tachycardia ) . Acute myocardial infarction within 12 week patient study registration . Known pulmonary embolism . Known suspected lung cancer . Known neuromuscular disease , stroke residual hemiparesis , untreated Parkinsonism Pregnant nursing woman woman childbearing potential use medically approve mean contraception ( i.e. , oral contraceptive , intrauterine device , diaphragm , sub dermal implant ) . Inability understand instruction . Participation another investigational drug clinical trial within 30 day patient study registration .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>COPD</keyword>
	<keyword>chronic obstructive pulmonary disease</keyword>
</DOC>